Vidaza | Annual Sales Report | Pharmacompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Vidaza
Annual Reports

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Jai Radhe Sales is your partner for all your sourcing needs.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Vidaza

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

38 API Suppliers, 21 USDMF, 3 JDMF, 6 EU WC, 8 KDMF, 16 NDC API, 26 Listed Suppliers, $ API Reference Price

38 API Suppliers
21 USDMF
3 JDMF
6 EU WC
8 KDMF
16 NDC API
26 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

154 Drugs in Development

154 Drugs in Development

INTERMEDIATES

3 Intermediates Suppliers

3 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

160 FDF Dossiers, 18 FDA Orange Book, 15 Europe, 7 Canada, 101 Australia, 3 South Africa, 16 Listed Dossiers

160 FDF Dossiers
18 FDA Orange Book
15 Europe
7 Canada
101 Australia
3 South Africa
16 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 12 SPI Pharma, 1 Faran Shimi Pharmaceutical, 2 Pfanstiehl, 1 Actylis, 1 BASF, 3 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 2 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Sigachi Industries

1 Rochem International Inc
12 SPI Pharma
1 Faran Shimi Pharmaceutical
2 Pfanstiehl
1 Actylis
1 BASF
3 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
2 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

17 Fillers, Diluents & Binders, 11 Taste Masking, 10 Chewable & Orodispersible Aids, 9 Direct Compression, 5 Parenteral, 4 Co-Processed Excipients, 3 Disintegrants & Superdisintegrants, 3 Thickeners and Stabilizers, 3 Granulation, 2 Coating Systems & Additives, 1 API Stability Enhancers

17 Fillers, Diluents & Binders
11 Taste Masking
10 Chewable & Orodispersible Aids
9 Direct Compression
5 Parenteral
4 Co-Processed Excipients
3 Disintegrants & Superdisintegrants
3 Thickeners and Stabilizers
3 Granulation
2 Coating Systems & Additives
1 API Stability Enhancers

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 1 STOCK RECAP #PipelineProspector, 111 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
1 STOCK RECAP #PipelineProspector
111 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

3 US Medicaid Prescriptions, 13 Finished Drug Prices, 20 Annual Reports

3 US Medicaid Prescriptions
13 Finished Drug Prices
20 Annual Reports

MARKET PLACE

9 APIs, 16 FDF Dossiers

9 APIs
16 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 4 US Exclusivities

6 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

4 USP, 5 Others

4 USP
5 Others

$ API Ref.Price (USD/KG) : 35,087 Xls

Filters

Reset all filters

Filters

FILTER :

filter Product Reset all filters

20 All

01 2Azacitidine For Injection

02 1Azacitidine for Injection

03 1Azacitidine for injection

04 1Kyprolis

05 4Onureg

06 5Vidaza

07 3Vidaza

08 1Vidaza - BMS

09 1Vidaza - Celgene

10 1azacitidine for Injection

List of Suppliers

Product Main Page

01

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bristol Myers Squibb

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 17

2019 Revenue in Millions : 0

Growth (%) : New Launch

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bristol Myers Squibb

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 455

2019 Revenue in Millions : 521

Growth (%) : -13

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 22

2020 Revenue in Millions : 33

Growth (%) : -35

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bristol Myers Squibb

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 73

2020 Revenue in Millions : 17

Growth (%) : 329

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 16

2021 Revenue in Millions : 22

Growth (%) : -26

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bristol Myers Squibb

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 124

2021 Revenue in Millions : 73

Growth (%) : 70

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Brand Name : Onureg

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Bristol Myers Squibb

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 168

2022 Revenue in Millions : 124

Growth (%) : 35

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Brand Name : Kyprolis

BioFlorida Conference

Not Confirmed

Brand Name : Kyprolis

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 15

2022 Revenue in Millions : 16

Growth (%) : -8

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Brand Name : Vidaza

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Celgene Corpoartion

Azacitidine

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 612

2014 Revenue in Millions : 591

Growth (%) : -3%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

Brand Name : Azacitidine for injection

BioFlorida Conference

Not Confirmed

Brand Name : Azacitidine for injection

BioFlorida Conference

Not Confirmed

Post an Enquiry

Post an Enquiry

Digital Content

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Celgene Corpoartion

Azacitidine

Main Therapeutic Indication :

Currency : USD

2015 Revenue in Millions : 78

2014 Revenue in Millions : 84

Growth (%) : 8%

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?